Lescol Xl 80

Fluvastatin, the active ingredient in Lescol XL 80, is a HMG‑CoA reductase inhibitor presented as an 80 mg tablet for oral use. It treats hypercholesterolemia and is employed for primary and secondary prevention of cardiovascular disease in adult patients. It is indicated for patients with elevated low‑density lipoprotein cholesterol levels and is part of a comprehensive lipid‑lowering strategy that includes diet and lifestyle modification.

GNH USA supplies Lescol XL 80 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Lescol XL 80 (fluvastatin) is used to manage disorders of lipid metabolism and reduce cardiovascular risk.

- Hypercholesterolemia: lowers low‑density lipoprotein (LDL) cholesterol and total cholesterol, helping achieve target lipid levels in patients with elevated LDL. - Primary prevention of cardiovascular disease: reduces the incidence of myocardial infarction, stroke, and related events in individuals without established atherosclerotic disease but with risk factors. - Secondary prevention of cardiovascular disease: decreases the risk of recurrent cardiovascular events in patients with a history of myocardial infarction, angina, or peripheral arterial disease.

Fluvastatin may cause a range of adverse reactions, from mild to serious, that should be monitored during therapy.

Common Side Effects: - Headache: mild to moderate headache reported in some patients. - Muscle pain (myalgia): occasional muscle discomfort without significant creatine kinase elevation. - Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia may occur. - Elevated liver enzymes: transient increases in ALT or AST are observed.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown with marked CK rise, potentially leading to renal failure. - Hepatotoxicity: significant elevation of liver transaminases or clinically apparent hepatitis. - Severe allergic reactions: rash, angioedema, or anaphylaxis requiring immediate medical attention. - Myocardial infarction (rare): isolated reports of acute coronary events have been described.

Before initiating Lescol XL 80, clinicians should consider several precautionary measures to ensure safe use.

- Liver function monitoring: obtain baseline ALT/AST and repeat periodically during therapy. - Renal impairment: assess kidney function; use with caution in severe renal disease. - Drug interaction review: evaluate concomitant medications that affect CYP3A4 metabolism. - Pregnancy and lactation: contraindicated; classified as Category X due to teratogenic risk. - Muscle symptoms: discontinue if unexplained muscle pain accompanied by elevated CK levels. - Store at ambient temperature: keep below 25 °C, protect from moisture in the original packaging.

Fluvastatin can interact with other medicines, altering its plasma concentration or increasing toxicity risk.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): may raise fluvastatin levels and risk of myopathy. - Gemfibrozil: combined use markedly increases risk of rhabdomyolysis. - Cyclosporine: elevates statin exposure, heightening potential for muscle toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: fluvastatin may potentiate anticoagulant effect; monitor INR closely. - Grapefruit juice: can modestly increase plasma concentrations; advise limited consumption.